Asabys Partners
Venture Capital
Active
Barcelona, Spain
25
21M
16
4.17
9
0.36
- Areas of investment
Summary
In 2018 was created Asabys Partners, which is appeared as VC. The fund was located in Europe if to be more exact in Spain. The leading representative office of defined VC is situated in the Barcelona.
Among the most popular portfolio startups of the fund, we may highlight Psious. For fund there is a match between the location of its establishment and the land of its numerous investments - Spain. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. Among the most successful fund investment fields, there are Wearables, Health Diagnostics.
The typical case for the fund is to invest in rounds with 3-4 participants. Despite the Asabys Partners, startups are often financed by Atlantic Labs, Rothenberg Ventures, Founders Factory. The meaningful sponsors for the fund in investment in the same round are Sabadell Venture Capital, Ysios Capital, Omega Funds.
The fund is constantly included in 2-6 investment rounds annually. The top activity for fund was in 2019. Deals in the range of 5 - 10 millions dollars are the general things for fund. Considering the real fund results, this VC is 80 percentage points more often commits exit comparing to other organizations.
The current fund was established by Clara Campas, Josep L.l. Sanfeliu.
Investor highlights
- Industry focus
- Stage focus
- Geo focus
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Last fund
- Fund size
- EUR 200000000
Analytics
- Total investments
- 25
- Lead investments
- 9
- Rounds per year
- 4.17
- Follow on index
- 0.36
- Investments by industry
- Health Care (16)
- Biotechnology (14)
- Medical Device (13)
- Medical (9)
- Life Science (6) Show 19 more
- Investments by region
-
- Spain (17)
- Belgium (2)
- Sweden (2)
- France (1)
- Germany (2) Show 1 more
- Peak activity year
- 2022
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 6
- Avg. valuation at time of investment
- 5M
- Group Appearance index
- 0.96
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| AgomAb Therapeutics | 11 Oct 2023 | Biotechnology, Health Care, Therapeutics | Late Stage Venture | 111M | East Flanders, Ghent, Belgium |
| Origo Biopharma | 07 Jul 2020 | Biotechnology, Pharmaceutical | Seed | 2M |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.